Dr Joshua Tobin is a Staff Specialist Haematologist at Princess Alexandra Hospital and Senior Research Fellow in the Blood Cancer Research Group at the University of Queensland Mater Research Institute, where his work centres on biomarker‑led, personalised immunotherapy trials in lymphoma. He completed a research fellowship at MD Anderson Cancer Center and is a recipient of competitive early‑career awards including the ASH Global Scholar Award, Mater Future Leaders Fellowship, and prior Snowdome Haematology Fellowship. Nationally, he is currently the secretary of the Lypmhoma Working Party for Australasian Leukaemia & Lymphoma Group and is Coordinating Primary Investigator for 3 national investigator led studies including TREB1 and TREBL2 virus‑specific T‑cell studies in EBV‑driven lymphomas and the CLARIFY prognostic platform enabling early CD19 CAR T referral in ultra‑high‑risk LBCL.